Radonjic-Hoesli, Susanne
Brüggen, Marie-Charlotte
Feldmeyer, Laurence
Simon, Hans-Uwe http://orcid.org/0000-0002-9404-7736
Simon, Dagmar http://orcid.org/0000-0001-8965-9407
Funding for this research was provided by:
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (310030_184816)
МЕГАГРАНТЫ
Article History
Received: 27 April 2021
Accepted: 6 May 2021
First Online: 7 June 2021
Declarations
:
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: H.U.S. is a consultant for GlaxoSmithKline. DS has been an investigator, advisory board member, or consultant for AbbVie, AstraZeneca, Galderma, LEO, Lilly, Pfizer, Roche Pharma, and Sanofi Genzyme. The other authors declare that they have no conflict of interest.